Stereotactic Body Radiation Therapy (SBRT): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Stereotactic Body Radiation Therapy (SBRT)

• A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
  NCT05361798 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
  NCT06492954 · Phase: Phase 1 · Ages: Up to 50 Years · Sex: All (male and female) · 1 location
• Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
  NCT05384496 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
  NCT07112170 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
  NCT06914440 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
  NCT04854213 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
  NCT06835725 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
  NCT06055881 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 2 locations
• Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
  NCT06705127 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Single Fractions SBRT for Prostate Cancer
  NCT04004312 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
  NCT06691425 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
  NCT06927635 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · 1 location
• Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
  NCT04402151 · Phase: Phase 2 · Ages: 21 Years to 90 Years · Sex: Male · 1 location
• Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
  NCT07142967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many recruiting trials involve Stereotactic Body Radiation Therapy (SBRT)?

15 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.